These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33332324)

  • 1. COVID-19 outbreaks in Aotearoa New Zealand: urgent action is required to address systematic causes and consequences of border failures.
    Kvalsvig A; Summers J; Gray L; Telfar-Barnard L; Baker MG
    N Z Med J; 2020 Dec; 133(1527):8-14. PubMed ID: 33332324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The next phase in Aotearoa New Zealand's COVID-19 response: a tight suppression strategy may be the best option.
    Baker MG; Kvalsvig A; Crengle S; Harwood M; Tukuitonga C; Betty B; Bonning J; Wilson N
    N Z Med J; 2021 Nov; 134(1546):8-16. PubMed ID: 34855729
    [No Abstract]   [Full Text] [Related]  

  • 3. Negotiating Health Amidst COVID-19 Lockdown in Low-income Communities in Aotearoa New Zealand.
    Elers C; Jayan P; Elers P; Dutta MJ
    Health Commun; 2021 Jan; 36(1):109-115. PubMed ID: 33222539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand.
    Geoghegan JL; Ren X; Storey M; Hadfield J; Jelley L; Jefferies S; Sherwood J; Paine S; Huang S; Douglas J; Mendes FK; Sporle A; Baker MG; Murdoch DR; French N; Simpson CR; Welch D; Drummond AJ; Holmes EC; Duchêne S; de Ligt J
    Nat Commun; 2020 Dec; 11(1):6351. PubMed ID: 33311501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand.
    Jelley L; Douglas J; Ren X; Winter D; McNeill A; Huang S; French N; Welch D; Hadfield J; de Ligt J; Geoghegan JL
    Nat Commun; 2022 Jul; 13(1):4035. PubMed ID: 35821124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 testing processes and patient protections for resumption of elective surgery.
    Schlosser M; Signorelli H; Gregg W; Korwek K; Sands K
    Am J Surg; 2021 Jan; 221(1):49-52. PubMed ID: 32736801
    [No Abstract]   [Full Text] [Related]  

  • 7. Exploring the depth and breadth of the genomics toolbox during the COVID-19 pandemic: insights from Aotearoa New Zealand.
    Bunce M; Geoghegan JL; Winter D; de Ligt J; Wiles S
    BMC Med; 2023 Jun; 21(1):213. PubMed ID: 37316857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased unemployment from the COVID-19 pandemic, what might be the adverse impacts on cardiovascular disease in Aotearoa/New Zealand and how might this be prevented?
    Nghiem N; Mizdrak A; Wilson N
    N Z Med J; 2020 Dec; 133(1526):89-98. PubMed ID: 33332343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New Zealand's COVID-19 Elimination Strategy - Is it Working?].
    Murdoch DR
    Laeknabladid; 2020 Sep; 106(9):393. PubMed ID: 32902396
    [No Abstract]   [Full Text] [Related]  

  • 10. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Going hard and early: Aotearoa New Zealand's response to Covid-19.
    Cumming J
    Health Econ Policy Law; 2022 Jan; 17(1):107-119. PubMed ID: 33663626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Zealand's elimination strategy for the COVID-19 pandemic and what is required to make it work.
    Baker M; Kvalsvig A; Verrall AJ; Telfar-Barnard L; Wilson N
    N Z Med J; 2020 Apr; 133(1512):10-14. PubMed ID: 32242173
    [No Abstract]   [Full Text] [Related]  

  • 13. New Zealand's science-led response to the SARS-CoV-2 pandemic.
    Geoghegan JL; Moreland NJ; Le Gros G; Ussher JE
    Nat Immunol; 2021 Mar; 22(3):262-263. PubMed ID: 33627881
    [No Abstract]   [Full Text] [Related]  

  • 14. Is oro/nasopharyngeal swab for SARS-CoV-2 detection a safe procedure? Complications observed among a case series of 4876 consecutive swabs.
    Fabbris C; Cestaro W; Menegaldo A; Spinato G; Frezza D; Vijendren A; Borsetto D; Boscolo-Rizzo P
    Am J Otolaryngol; 2021; 42(1):102758. PubMed ID: 33125901
    [No Abstract]   [Full Text] [Related]  

  • 15. Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting.
    Oshman L; Caplan A; Ali R; Singh L; Khalid R; Jameel M; David SP
    J Prim Care Community Health; 2020; 11():2150132720981297. PubMed ID: 33300408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose chest CT had 95% sensitivity and 91% specificity for diagnosing COVID-19 in patients with clinical symptoms.
    Long B
    Ann Intern Med; 2020 Dec; 173(12):JC68. PubMed ID: 33316180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time estimation of the effective reproduction number of SARS-CoV-2 in Aotearoa New Zealand.
    Binny RN; Lustig A; Hendy SC; Maclaren OJ; Ridings KM; Vattiato G; Plank MJ
    PeerJ; 2022; 10():e14119. PubMed ID: 36275456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting the re-emergent COVID-19 pandemic after elimination: modelling study of combined primary care and hospital surveillance.
    Wilson N; Schwehm M; Verrall AJ; Parry M; Baker MG; Eichner M
    N Z Med J; 2020 Oct; 133(1524):28-39. PubMed ID: 33119568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple Questionnaires to Improve Pooling Strategies for SARS-CoV-2 Laboratory Testing.
    Schneitler S; Jung P; Bub F; Alhussein F; Benthien S; Berger FK; Berkó-Göttel B; Eisenbeis J; Hahn D; Halfmann A; Last K; Linxweiler M; Lohse S; Papan C; Pfuhl T; Rissland J; Roth S; Schlotthauer U; Utzinger J; Smola S; Gärtner BC; Becker SL
    Ann Glob Health; 2020 Nov; 86(1):148. PubMed ID: 33262937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 from Wellington New Zealand.
    Gray B
    J Bioeth Inq; 2020 Dec; 17(4):633-638. PubMed ID: 33169244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.